InvestorsHub Logo
Followers 1
Posts 214
Boards Moderated 0
Alias Born 07/28/2020

Re: None

Tuesday, 05/17/2022 10:30:45 AM

Tuesday, May 17, 2022 10:30:45 AM

Post# of 163959

At December 31, 2021 our cash position was $151,175 and we had an accumulated deficit of $51,410,516.

Just gets worse and worse with every report. This place hemorrhages money.

There is no assurance that any significant public market for our shares of common stock will develop.

But what about the 100s of investors on the preapproved list that have 100s of millions of shares locked up!

We have never paid or declared any cash dividends on our common stock and we do not intend to pay or declare dividends on our common stock in the near future.

So much for that idea.

The increase in revenues from operations was principally due to the success of the high impact closing to remodel sale at Rotmans which took place in the first quarter of 2021.

Furniture sales still seem to be driving the business, and in this case, primarily from a single sale in the first quarter of the year.

There can be no assurances that we will be able to achieve projected levels of revenue in 2022 and beyond. If we are not able to achieve projected revenue and obtain alternate additional financing of equity or debt, we would need to significantly curtail or reorient operations during 2022, which could have a material adverse effect on our ability to achieve our business objectives and as a result, may require the Company to file for bankruptcy or cease operations.

Straight from the horse's mouth.

In the event that the spin-off of RxAir does not occur within 2022

Given that it's supposed to be happening in the next month or 2, this certainly rings of an attempt to set investors up for disappointment.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent VYST News